Daparyl-VM 5/1000 Tablet SR
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Dapagliflozin (5mg) + Metformin (1000mg) + Vildagliptin (100mg)
Overview Daparyl-VM 5/1000 Tablet SR
Glyciphage-XR 5/1000mg sustained-release tablets are a dual-action medication designed to manage blood glucose. This medication complements a healthy diet and exercise regimen to enhance glycemic control in adult patients with type 2 diabetes. It facilitates efficient insulin use, consequently reducing blood sugar. Glyciphage-XR 5/1000mg should be ingested with meals. Dosage is determined by your physician and should not be altered without their explicit instruction. Sudden cessation may lead to elevated blood glucose, risking severe complications such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Common adverse effects include vaginal candidiasis, upper respiratory infection, cystitis, diarrhea, cephalalgia, nausea, and emesis. Adequate hydration is crucial to mitigate dehydration. Practicing good hygiene minimizes the risk of genital fungal infections. Prior to commencing Glyciphage-XR 5/1000mg, disclose any renal or hepatic dysfunction, urinary tract infections, or diuretic use to your physician. Pregnant or lactating women must seek medical counsel before initiating treatment. Excessive alcohol consumption should be avoided, as it may heighten the likelihood of side effects. Regular blood glucose monitoring is essential.
Primary Ingredients of Daparyl-VM 5/1000 Tablet SR
There is no text provided to rephrase.
Uses of Daparyl-VM 5/1000 Tablet SR
Managing Type 2 Diabetes
Major Benefits of Daparyl-VM 5/1000 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and timeframe. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Daparyl-VM 5/1000 Tablet SR should be administered with a meal.
Common Side effects of Daparyl-VM 5/1000 Tablet SR:
- Vaginal yeast infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Diarrhea
- Headache
- Nausea
- Vomiting
How to use Daparyl-VM 5/1000 Tablet SR:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Daparyl-VM 5/1000 Tablet SR with a meal.
How Daparyl-VM 5/1000 Tablet SR works:
Daparyl-VM 5/1000 SR tablets contain a triple-action formula to manage blood sugar. Dapagliflozin works by enhancing glucose elimination via the urine, consequently lowering blood glucose. Vildagliptin boosts insulin production by stimulating incretin hormones, which also signal the liver to curtail glucose output when levels are elevated. Metformin acts by reducing glucose absorption from ingested food and hepatic glucose production, while simultaneously improving the body's insulin sensitivity, thus regulating blood glucose.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when using Daparyl-VM 5/1000 Tablet SR concurrently with alcohol. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Daparyl-VM 5/1000 SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Daparyl-VM 5/1000 tablet is likely not safe for use while breastfeeding. Scant evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCONSULT YOUR DOCTOR
Daparyl-VM 5/1000 Tablet SR's effect on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
For individuals with kidney impairment, Daparyl-VM 5/1000 Tablet SR presents a safe treatment option. No dosage modification is necessary for this medication.
LiverUNSAFE
Sustained-release Daparyl-VM 5/1000 tablets are contraindicated in individuals with hepatic impairment and should be omitted. Seek medical advice.
What if you forget to take Daparyl-VM 5/1000 Tablet SR :
Should you forget a Daparyl-VM 5/1000 Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Daparyl-VM 5/1000 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |


